The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ohio Oncology and Hematology, LLC
Leadership - Ohio Oncology and Hematology, LLC
Consulting or Advisory Role - Bayer; Puma Biotechnology
 
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Celgene
Travel, Accommodations, Expenses - Celgene
Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R2-CHOP in subjects with previously untreated, high-risk DLBCL.
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Wolfgang Willenbacher
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Novartis; Roche; Takeda
Speakers' Bureau - Gilead Sciences
Research Funding - Amgen; Celgene; Janssen; Takeda
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen Biotech; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Gilead Sciences; Janssen; MSD; Novartis; Roche
 
Thomas Stauffer Larsen
Travel, Accommodations, Expenses - Abbvie
 
Krish Patel
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech; Juno Therapeutics; Sunesis Pharmaceuticals; Verastem
Speakers' Bureau - AstraZeneca; Genentech; Pharmacyclics/Janssen
Research Funding - Aptevo Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); Takeda (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - MEI Pharma
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; AOP Orphan Pharmaceuticals; Bioverativ; Bristol-Myers Squibb; Celgene; Emergent BioSolutions; Gilead Sciences; Janssen-Cilag; Mundipharma; Novartis; Roche; Sandoz; Takeda; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Abbvie (Inst); Bioverativ (Inst); Celgene (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen-Cilag (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Robert F. Manges
No Relationships to Disclose
 
Lorenz H. Trumper
Consulting or Advisory Role - Nordic Nanovector; Seagen; Takeda
Research Funding - Amgen; Roche; Spectrum Pharmaceuticals
 
Corinne Haioun
Honoraria - Amgen; Gilead Sciences; Novartis; SERVIER
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Roche
 
Hele Everaus
Travel, Accommodations, Expenses - Sanofi
 
Nagesh Kalakonda
Research Funding - Celgene
 
Jeanna Knoble
No Relationships to Disclose
 
Peter Brown
Consulting or Advisory Role - Celgene
 
Judit Meszaros Joergensen
Stock and Other Ownership Interests - Bristol-Myers Squibb; Gilead Sciences; Novo Nordisk
Consulting or Advisory Role - Gilead Sciences
Research Funding - Celgene; Gilead Sciences; Roche
Travel, Accommodations, Expenses - Gilead Sciences
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Neus Domper
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Celgene
Travel, Accommodations, Expenses - Celgene
 
Marie-Laure Casadebaig
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Oliver Manzke
No Relationships to Disclose
 
Javier Munoz
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - AstraZeneca; Bayer; Gilead Sciences; Kite, a Gilead company; Pharmacyclics/Janssen